3-47122339-A-G
Variant summary
Our verdict is Likely benign. The variant received -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_014159.7(SETD2):c.2297T>C(p.Met766Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000186 in 1,614,102 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. M766V) has been classified as Uncertain significance.
Frequency
Consequence
NM_014159.7 missense
Scores
Clinical Significance
Conservation
Publications
- Luscan-Lumish syndromeInheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics
- SETD2-related neurodevelopmental disorder without or with macrocephaly/overgrowthInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- Rabin-Pappas syndromeInheritance: AD Classification: STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
- SETD2-related microcephaly-severe intellectual disability-multiple congenital anomalies syndromeInheritance: AD Classification: STRONG Submitted by: ClinGen
- Sotos syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- intellectual developmental disorder, autosomal dominant 70Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -2 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| SETD2 | NM_014159.7 | c.2297T>C | p.Met766Thr | missense_variant | Exon 3 of 21 | ENST00000409792.4 | NP_054878.5 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| SETD2 | ENST00000409792.4 | c.2297T>C | p.Met766Thr | missense_variant | Exon 3 of 21 | 5 | NM_014159.7 | ENSP00000386759.3 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152266Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.00000398 AC: 1AN: 251232 AF XY: 0.00 show subpopulations
GnomAD4 exome AF: 0.00000137 AC: 2AN: 1461836Hom.: 0 Cov.: 34 AF XY: 0.00 AC XY: 0AN XY: 727212 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152266Hom.: 0 Cov.: 32 AF XY: 0.0000134 AC XY: 1AN XY: 74396 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
The c.2297T>C (p.M766T) alteration is located in exon 3 (coding exon 3) of the SETD2 gene. This alteration results from a T to C substitution at nucleotide position 2297, causing the methionine (M) at amino acid position 766 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear.
not specified Other:1
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at